Document is current
Any future updates will be listed below
-
Authors
Wang, Lina
Rosenfeldt, Mads
Koutsaviti, Aikaterini
Harizani, Maria
Zhao, Yong https://orcid.org/0000-0002-0423-5232
Leelahakorn, Nattawat https://orcid.org/0000-0003-1327-6500
Frachon, Axelle
Raadam, Morten H. https://orcid.org/0000-0002-6796-0079
Miettinen, Karel https://orcid.org/0000-0003-2496-8924
Pateraki, Irini https://orcid.org/0000-0002-7526-2334
Ioannou, Efstathia https://orcid.org/0000-0003-3103-4951
Kampranis, Sotirios C. https://orcid.org/0000-0001-6208-1684
-
Funding
Funding for this research was provided by:
Novo Nordisk Fonden (NNF19OC0055204, NNF22OC0080100)
Det Frie Forskningsråd (4258-00065B)
China Scholarship Council (201909370090)
- License Information
-
More Information
Article History
Received: 23 June 2024
Accepted: 24 February 2025
First Online: 1 March 2025
Competing interests
: L.W., M.R., and S.C.K. are co-inventors of a patent application (WO2023006699A1) describing the use of AtFKI to phosphorylate a primary alcohol to a mono- or pyrophosphate terpenoid precursor. A.F. is an employee of EvodiaBio ApS. S.C.K. has financial interests in EvodiaBio ApS. The remaining authors declare no competing interest.
